SciELO - Scientific Electronic Library Online

 
vol.20 issue1-2Effect of two nutrition education methodologies in adolescents’ intake and knowledge about recommendations of fruit and vegetablesThe use of a new FISH technique in the study of idiopathic mental retardation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Arquivos de Medicina

On-line version ISSN 2183-2447

Abstract

PEREIRA, Ana Maria et al. IgG Antibodies to Cyclic Citrullinated Peptide (CCP) in patients with rheumatoid arthritis, other rheumatic disorders and healthy controls . Arq Med [online]. 2006, vol.20, n.1-2, pp.13-18. ISSN 2183-2447.

Background: Rheumatoid arthritis (RA) is a systemic auto-immune disorder and one of the most severe and disabling chronic rheumatic diseases. The objective of this study was to evaluate serum anti-cyclic citrullinated antibodies (anti--CCP) as a new diagnostic tool in RA. Methods: IgG anti-CCP was measured by a second generation enzyme immunoassay, C-reactive protein (CRP) and IgM Rheumatoid Factor (RF) by nephelometry and anti-keratin antibodies (AKA) by indirect immunoflorescence. We evaluated the clinical performance of these tests in terms of sensitivity, specificity, and positive predicted ratio. We studied 57 patients, subsequently classified according to their clinical records in RA (n=33) or other rheumatic disorders (diffuse connective tissue disorders - DCTD: Systemic Lupus Erythematosus n=10, Sjogren Syndrome n=3, Systemic Sclerosis n=6 and Arthropathies n=5) and 30 healthy persons as controls. Results: In RA, IgG anti-CCP levels were significantly higher than in the other rheumatic disorders (median 188.7U versus 0.30U p

Keywords : autoimmunity; rheumatoid arthritis; IgG anti-CCP; anti-keratin; rheumatoid facto; CRP; diagnosis.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License